Daniel Kazado, Director at IMMUNE PHARMACEUTICALS INC (IMNP), bought 8,000 shares at $2.50 ($20K) on 2014-11-26, disclosed to the SEC on 2014-12-03.
Open-market purchase of $20k IMNP by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| Filing → |
| IMNP | BUY | 2016-08-04 | $600K | — | Filing → |
| IMNP | BUY | 2015-12-08 | $117K | — | Filing → |
| IMNP | BUY | 2015-09-16 | $74K | — | Filing → |